— Know what they know.
Not Investment Advice

BPTH OTC

Bio-Path Holdings, Inc.
1W: -40.0% 1M: -98.5% 3M: -99.3% YTD: -99.5% 1Y: -99.6% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±197.0%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $934 mcap · 9M float · 0.359% daily turnover · Short 61% of daily vol

Balance Sheet Trends

Total Assets
$4M +20.6% ▲
5Y CAGR: -29.7%
Total Liabilities
$4M +34.2% ▲
5Y CAGR: +18.8%
Shareholders Equity
$154K -65.1% ▼
5Y CAGR: -62.6%
Cash & Investments
$1M +11.5% ▲
5Y CAGR: -43.5%
Total Debt
$83K -26.5% ▼
5Y CAGR: -27.5%
Net Debt
-$1M -16.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$14M$24M$10M$1M$1M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$14M$24M$10M$1M$1M
Net Receivables$0$0$0$0$0
Inventory$1K$523$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$16M$26M$16M$3M$4M
Property, Plant & Equip.$519K$428K$356K$178K$84K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$23K
Total Non-Current Assets$519K$428K$356K$178K$107K
Total Assets$16M$27M$16M$3M$4M
— Liabilities —
Accounts Payable$100K$106K$667K$457K$1M
Short-Term Debt$94K$82K$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$481K$288K$0$1M$0
Total Current Liabilities$1M$958K$2M$2M$3M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$863K$434K
Total Non-Current Liabilities$236K$153K$113K$873K$434K
Total Liabilities$1M$1M$2M$3M$4M
— Equity —
Common Stock$5K$7K$1K$1K$6K
Retained Earnings-$67M-$78M-$92M-$108M-$118M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$15M$25M$14M$441K$154K
Total Liabilities & Equity$16M$27M$16M$3M$4M
— Key Metrics —
Total Debt$330K$235K$221K$113K$83K
Net Debt-$13M-$24M-$10M-$939K-$1M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms